Skip to content
2000
Volume 19, Issue 10
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

Anticancer agents play a vital role in the cure of patients suffering from malignancy. Though, the chemotherapeutic agents are associated with various adverse effects which produce significant toxic symptoms in the patients. But this therapy affects both the malignant and normal cells and leads to constricted therapeutic index of antimalignant drugs which adversely impacts the quality of patients’ life. Due to these adversities, sufficient dose of drug is not delivered to patients leading to delay in treatment or improper treatment. Chemoprotective agents have been developed either to minimize or to mitigate the toxicity allied with chemotherapeutic agents. Without any concession in the therapeutic efficacy of anticancer drugs, they provide organ specific guard to normal tissues.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/1568009619666190326120457
2019-11-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/1568009619666190326120457
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test